Why the study?
Does octyl gallate attenuate atherosclerosis and improve serum lipid profiles and macrophage cholesterol homeostasis in preclinical models?
Does octyl gallate attenuate atherosclerosis and improve serum lipid profiles and macrophage cholesterol homeostasis in preclinical models?
Answers are grounded in this paper and cite their sources.
Octyl gallate shows preclinical potential as an anti-atherosclerotic agent by improving lipid profiles and reducing inflammation and oxidative stress via the PPARγ-LXRα-ABCA1/ABCG1 and NRF2-NQO1 pathways.
mice. OG also improved serum lipid profiles by reducing low-density lipoprotein cholesterol (LDL-C) and total cholesterol levels, increasing high-density lipoprotein cholesterol (HDL-C) levels. In addition, OG decreased IL-1β and TNF-α expression in the aortic root. Network pharmacology, molecular docking and molecular dynamics simulations identified PPARγ as a potential molecular target of OG. Further experiments demonstrated that OG enhanced the expression of PPARγ, LXRα, ABCA1, and ABCG1 in ox-LDL-treated macrophages. Moreover, OG suppressed inflammatory responses and reactive oxygen species (ROS) accumulation while activating the NRF2-NQO11 antioxidant system and promoting NRF2 nuclear translocation. Collectively, these findings suggest that OG may exert anti-atherosclerotic effects by coordinating macrophage lipid metabolism, redox homeostasis, and inflammatory responses through the PPARγ-LXRα-ABCA1/ABCG1 axis and the NRF2-NQO1 antioxidant pathway, respectively. These results provide experimental evidence supporting the potential of OG as a candidate compound for the prevention and treatment of AS.
No takes yet. Share an insight, caveat, or question.
Hua et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: